Regulatory Affairs Consulting
Across the Device Lifecycle
BioVision provides expert regulatory affairs support spanning the entire lifecycle of your medical device - from early development strategy through to post-market obligations. A clear regulatory strategy set early prevents the costly redesigns, testing gaps, and delays that derail so many device launches.
Where regulatory strategy makes the difference
-
Development stage - defining your intended use, classification, and target-market requirements before design decisions are locked.
-
Submission stage - selecting the optimal pathway and assembling a compelling dossier.
-
Post-market stage - surveillance, change management, and maintaining compliance across markets.
How BioVision helps
-
Regulatory strategy and market-entry roadmaps.
-
Classification across multiple jurisdictions.
-
Submission planning and management.
-
Change and lifecycle management.
-
Regulatory intelligence on evolving requirements.
Frequently Asked Questions
What is regulatory affairs in the medical device industry?
Regulatory affairs is the discipline of ensuring a device meets all applicable regulations to reach and remain on the market. It spans strategy, submissions, and ongoing compliance.
Why engage a regulatory affairs consultant early?
Decisions made during development - about intended use, materials, and testing - directly shape what regulators will require. Early strategy avoids expensive rework.